Komori
Eiken Chemical (4549) · InitiativeAchieved

Cancellation of 5 Million Treasury Shares

First written in FY2024-Q2. 5 of 8 entries say "Advanced", first in FY2024-Q3. Latest entry: FY2026.

8entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2024-Q3 – FY20262023: 120232024: 320242025: 220252026: 22026
Same theme, other companies
Reducing Shares Outstanding Through the Cancellation of Treasury SharesA theme 156 companies write about · 0 as a headwind · 161 as a tailwind

76 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 156 companies compared. The sentences above are computed from all 156.
Full recordFilings, disclosures and news, newest first
  1. FY2026AchievedAnnual report

    「Acquired treasury shares cancelled during the fiscal year 4,000,000 shares」

    The 4 million treasury shares approved for cancellation in October 2025 were cancelled on 14 November 2025, completing the plan.
  2. 2026-05-12AchievedEarnings

    「The decrease of 4,000,000 shares in the total number of issued common shares resulted from the cancellation of treasury shares based on a resolution of the Board of Directors.」

    The previously announced cancellation of 4 million treasury shares has been completed.
  3. FY2026-H1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 30 October 2025, the Company decided the following matters concerning the cancellation of treasury shares pursuant to Article 178 of the Companies Act. (1) Class of shares to be cancelled: common shares (2) Total number of shares to be cancelled: 4,000,000 shares (Equivalent to 10.38% of the total number of issued shares including treasury shares before the cancellation) (3) Scheduled cancellation date: 14 November 2025」

    The Company newly announced its decision to cancel 4 million treasury shares, equivalent to 10.38% of total issued shares, on 14 November 2025.
  4. FY2025AdvancedAnnual report

    「Treasury shares acquired during the fiscal year 1,217,200 2,671,859,600 Total number and aggregate value of shares under the remaining resolution 782,800 2,328,410,400」

    Under its treasury share acquisition policy, the Company acquired 1,217,200 shares for approximately ¥2.671 billion during the fiscal year, leaving an authorization for 782,800 shares. It acquired an additional 580,700 shares by the filing date.
  5. FY2025-H1AdvancedAnnual report

    「Based on a resolution of the Board of Directors meeting held on 24 April 2024, the Company cancelled 1,500,000 treasury shares on 26 April 2024. As a result, during the interim consolidated accounting period, capital surplus decreased by ¥38 million, retained earnings by ¥1.528 billion and treasury shares by ¥1.567 billion.」

    In connection with the policy of cancelling 5 million treasury shares, the Company cancelled 1.5 million shares on 26 April 2024.
  6. FY2024-Q3AdvancedAnnual report

    「Total number of shares that may be acquired: 2,700,000 shares (maximum) (7.28% of total issued shares excluding treasury shares) Total acquisition cost: ¥5.4 billion (maximum) Acquisition period: 31 January 2024 to 30 June 2024 Acquisition method: Purchase through the Tokyo Stock Exchange's off-auction purchase of treasury shares (ToSTNeT-3) Total number of shares acquired: 1,000,000 shares Acquisition date: 31 January 2024 Treasury share cancellation results: Total number of shares cancelled: 1,000,000 shares Cancellation date: 9 February 2024」

    The Company resolved to acquire up to 2.7 million treasury shares for ¥5.4 billion and cancel the acquired shares. It acquired 1 million shares and cancelled them on 9 February 2024.
  7. FY2024-Q3AdvancedAnnual report

    「Based on a resolution of the Board of Directors meeting held on 21 November 2023, the Company cancelled 2,500,000 treasury shares on 30 November 2023. As a result, during the cumulative third-quarter consolidated period, capital surplus decreased by ¥242 million, retained earnings by ¥946 million and treasury shares by ¥1.188 billion.」

    Of the maximum 5 million treasury shares approved for cancellation in October 2023, 2.5 million shares were cancelled on 30 November 2023. Part of the plan moved to execution.
  8. FY2024-Q2First statedAnnual report

    「At a meeting of the Board of Directors held on 26 October 2023, the Company resolved the following matters concerning the cancellation of treasury shares pursuant to Article 178 of the Companies Act. Details of the treasury share cancellation: (1) Class of shares to be cancelled: common shares (2) Total number of shares to be cancelled: 5,000,000 shares (maximum), equivalent to 11.48% of the total number of issued shares including treasury shares before the cancellation (3) Scheduled cancellation date: 30 November 2023」

    At a meeting of the Board of Directors held on 26 October 2023, the Company resolved to cancel up to 5 million treasury shares, equivalent to 11.48% of total issued shares, with 30 November 2023 set as the scheduled cancellation date.
Moved together

"Accelerating Global Expansion" moved the same way as this thread, in the same document, in 5 of its 7 moves.

555443★123456
  1. ★This thread
  2. 1Accelerating Global Expansion5×
  3. 2Market Expansion of Fecal Occult Blood and Urine Testing Products in Overseas Markets5×
  4. 3Strengthening the Financial Position by Reducing Total Assets and Improving Capital Efficiency5×
  5. 4Expansion of Production Capacity and Construction of a New Manufacturing Facility4×
  6. 5Sluggish Overseas Sales Growth and Stagnation in North American Fecal Occult Blood Products4×
  7. 6Development of Global Products and Commercialization of New Products3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Eiken Chemical's next results are scheduled for 2026-10-29. Read the earnings preview It last moved in the Earnings of 2026-05-12: "Achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Cancellation of 5 Million Treasury Shares | EIKEN CHEMICAL CO.,LTD. (4549) | Komori